Advertisement
Advertisement
U.S. Markets open in 5 hrs 17 mins
Advertisement
Advertisement
Advertisement
Advertisement

OncoCyte Corporation (OCX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.40000.0000 (0.00%)
At close: 4:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/27/2021
Current
Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.91
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 36.5700
52 Week Low 31.4100
50-Day Moving Average 33.6078
200-Day Moving Average 34.5372

Share Statistics

Avg Vol (3 month) 3604.8k
Avg Vol (10 day) 3300.74k
Shares Outstanding 589.87M
Implied Shares Outstanding 6N/A
Float 853.01M
% Held by Insiders 110.33%
% Held by Institutions 163.54%
Shares Short (Sep 29, 2021) 42.3M
Short Ratio (Sep 29, 2021) 44.6
Short % of Float (Sep 29, 2021) 43.76%
Short % of Shares Outstanding (Sep 29, 2021) 42.48%
Shares Short (prior month Aug 30, 2021) 42.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-826.26%

Management Effectiveness

Return on Assets (ttm)-18.06%
Return on Equity (ttm)-38.67%

Income Statement

Revenue (ttm)4.21M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)1,319.60%
Gross Profit (ttm)-639k
EBITDA -32.86M
Net Income Avi to Common (ttm)-27.5M
Diluted EPS (ttm)-0.3700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)47.53M
Total Cash Per Share (mrq)0.52
Total Debt (mrq)6.67M
Total Debt/Equity (mrq)6.50
Current Ratio (mrq)2.53
Book Value Per Share (mrq)1.20

Cash Flow Statement

Operating Cash Flow (ttm)-30.07M
Levered Free Cash Flow (ttm)-3.1M
Advertisement
Advertisement